USP22 exerts tumor-suppressive functions in colorectal cancer by decreasing mTOR activity.
Ontology highlight
ABSTRACT: USP22, the deubiquitinating subunit of the SAGA transcriptional cofactor complex, is a member of an 11-gene "death-from-cancer" signature. USP22 has been considered an attractive therapeutic target since high levels of its expression were associated with distant metastasis, poor survival, and high recurrence rates in a wide variety of solid tumors, including colorectal cancer (CRC). We sought to investigate the role of Usp22 during tumorigenesis in vivo using a mouse model for intestinal carcinogenesis with a tissue-specific Usp22 ablation. In addition, we assessed the effects of USP22 depletion in human CRC cells on tumorigenic potential and identified underlying molecular mechanisms. For the first time, we report that USP22 has an unexpected tumor-suppressive function in vivo. Intriguing
SUBMITTER: Kosinsky RL
PROVIDER: S-EPMC7205880 | biostudies-literature | 2020 Apr
REPOSITORIES: biostudies-literature
ACCESS DATA